FJTKX | RBHTX | FJTKX / RBHTX | |
Total Expense Ratio | 0.45 | 1.46 | 31% |
Annual Report Gross Expense Ratio | 0.45 | 1.46 | 31% |
Fund Existence | 8 years | 18 years | - |
Gain YTD | 8.799 | 10.500 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.5B | 41.7B | 54% |
Annual Yield % from dividends | 1.50 | 0.42 | 354% |
Returns for 1 year | 7.78 | 9.50 | 82% |
Returns for 3 years | 49.61 | 39.03 | 127% |
Returns for 5 years | 38.04 | 39.30 | 97% |
Returns for 10 years | N/A | 70.58 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 21.59 | 0.53 | +2.52% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
IQSU | 49.68 | 0.18 | +0.37% |
NYLI Candriam U.S. Large Cap Equity ETF | |||
ETV | 13.74 | 0.04 | +0.29% |
Eaton Vance Tax-Managed Buy-Write Opportunities Fund | |||
TAIL | 11.81 | N/A | N/A |
Cambria Tail Risk ETF | |||
ELC | 20.26 | -0.12 | -0.59% |
Entergy Louisiana LLC |